Key facts
- This page summarizes William D. Baird III's Form 4 filing for 2seventy bio, Inc. (TSVT).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 08 Jan 2025, 18:50.
William D. Baird III - 06 Jan 2025 Form 4 Insider Report for 2seventy bio, Inc. (TSVT)
- Reporting relationship
- President and CEO, Director
- Issuer ticker
- TSVT
- Reported as of
- 06 Jan 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 08 Jan 2025, 18:50:56 UTC
- Prior SEC filing
- 07 Jan 2025
- Next SEC filing
- 19 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Iya Kessler, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
William D. Baird III filed Form 4 for 2seventy bio, Inc. (TSVT) on 08 Jan 2025.
Change
- Previous filing in this sequence was filed on 07 Jan 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TSVT
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +264,000
- Change %
- +31%
- Price
- $0.000000
- Shares after
- 1,126,126
- Date
- 06 Jan 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TSVT
transaction
Derivative
Stock Option (Right to buy)
Award
- Transaction value
- $0
- Shares
- +176,000
- Change %
- Price
- $0.000000
- Shares after
- 176,000
- Date
- 06 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 176,000
- Exercise price
- $2.64
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
This restricted stock unit award vests ratably over a four-year period in annual installments with the first installment vesting on January 2, 2026, subject to the Reporting Person's continued service through the applicable vesting date.
Footnote F2
This stock option vests over a four-year period at the rate of 25% on January 2, 2026, and then in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.